Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacogenomics of Antidepressant Response in Taiwanese Patients
NCT00269334Phase 4Unknown
- Sponsor
- National Health Research Institutes
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of citalopram and paroxetine in major depressive disorder (MDD), sponsored by National Health Research Institutes. Primary endpoint: Structured Clinical Interview for DSM-IV Disorders at 0 weeks. Status: unknown.
02
Drugs
citalopramparoxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00269334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00269334.